2012
DOI: 10.1038/484167c
|View full text |Cite
|
Sign up to set email alerts
|

Primate studies: Trials don't always translate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 2 publications
0
4
0
Order By: Relevance
“…However, for many years the presumed benefits of NHP research for medical advances were not subjected to rigorous critical evaluation. In recent years however, evidence-based assessments have been conducted, frequently demonstrating that NHP models have provided disappointing contributions toward human medical advancements [9,10,11,12].…”
Section: Non-human Primates In Laboratory Researchmentioning
confidence: 99%
See 2 more Smart Citations
“…However, for many years the presumed benefits of NHP research for medical advances were not subjected to rigorous critical evaluation. In recent years however, evidence-based assessments have been conducted, frequently demonstrating that NHP models have provided disappointing contributions toward human medical advancements [9,10,11,12].…”
Section: Non-human Primates In Laboratory Researchmentioning
confidence: 99%
“…NHPs are frequently used in drug trials which are often considered very promising [6]. However, retrospective examinations have demonstrated that the majority of those promising trials failed to translate to humans, or to produce the expected benefits [11], usually because of failures of safety or efficacy [89]. In fact, data from the Food and Drug Administration showed that 92% of drugs that succeed in preclinical tests fail to achieve their purpose within human clinical trials, and never reach the market [90].…”
Section: The Ethical Framework Of Deontology and Utilitarianismmentioning
confidence: 99%
See 1 more Smart Citation
“…Rodent testing, specifically the inhalation-based local lymph node assay (LLNA), is currently the only validated method with some level of acceptance. Still, it is resource intensive, not readily suited to high-throughput screening, and subject to ethical controversy, and the results do not always translate accurately to humans (Hackam and Redelmeier 2006 ; Bracken 2009 ; Hoymann 2012 ; Thew 2012 ; Stoccoro et al 2013 ; Fröhlich and Salar-Behzadi 2014 ). In vitro studies using human-derived cells may allow for cost-effective rapid assessment, with fewer confounders factors introduced by a dynamic in vivo organism, as well as the assessment of species-specific responses.…”
Section: Introductionmentioning
confidence: 99%